H.Res. 484 · 117th Congress
Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.
- Stage
- In committee
- Sponsor
- Mariannette Miller-Meeks
- Introduced
- 2021-06-17
- Latest action
- 2022-11-01 · Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.